PULSE BIOSCIENCES, INC. (PLSE)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

-300K 0 300K 600K 900K Q3 '21: 574K Q4 '21: 844K Q1 '22: 444K Q2 '22: 265K Q3 '22: 0 Q4 '22: -9K Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 0 Q1 '24: 0 Q2 '24: 0 Q3 '24: 0 Q4 '24: 0 Q1 '25: 0 Q2 '25: 0 Q3 '25: 86K Q4 '25: 264K Q1 '26: 401K Q2 '26: 434K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

-9M -6M -3M 0 3M 6M 9M Q3 '21: -153K Q4 '21: -397K Q1 '22: -465K Q2 '22: -1.1M Q3 '22: -8.4M Q4 '22: -1.3M Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 0 Q3 '24: 0 Q4 '24: 0 Q1 '25: 0 Q2 '25: 0 Q3 '25: -193K Q4 '25: 4K Q1 '26: 31K Q2 '26: 161K Q1 '22 Q4 '22 Q3 '23 Q4 '24 Q3 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-27M -18M -9M 0 9M 18M 27M Q1 '16: -1.7M Q2 '16: -2.3M Q3 '16: -2.8M Q4 '16: -2.8M Q1 '17: -3.2M Q2 '17: -6.2M Q3 '17: -7.5M Q4 '17: -8.7M Q1 '18: -8.7M Q2 '18: -9.2M Q3 '18: -10.8M Q4 '18: -9M Q1 '19: -10.1M Q2 '19: -11.4M Q3 '19: -11.7M Q4 '19: -13.8M Q3 '20: -12.9M Q4 '20: -13.8M Q1 '21: -18.5M Q2 '21: -14.8M Q3 '21: -14.3M Q4 '21: -15.4M Q1 '22: -17.3M Q2 '22: -14M Q3 '22: -18M Q4 '22: -8.7M Q1 '23: -9.6M Q2 '23: -10.2M Q3 '23: -11.3M Q4 '23: -12.5M Q1 '24: -10.6M Q2 '24: -11.7M Q3 '24: -13.7M Q4 '24: -20.3M Q1 '25: -18M Q2 '25: -20.3M Q3 '25: -20.4M Q4 '25: -18.3M Q1 '26: -19.1M Q2 '26: -25.3M Q1 '17 Q2 '18 Q3 '19 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-27M -18M -9M 0 9M 18M 27M Q3 '16: -2.8M Q4 '16: -2.8M Q1 '17: -3.2M Q2 '17: -6.2M Q3 '17: -7.5M Q4 '17: -8.7M Q1 '18: -8.7M Q2 '18: -9.2M Q3 '18: -10.8M Q4 '18: -9M Q1 '19: -10.1M Q2 '19: -11.4M Q3 '19: -11.7M Q4 '19: -13.8M Q1 '20: -11.9M Q2 '20: -11.3M Q3 '20: -12.9M Q4 '20: -13.8M Q1 '21: -18.6M Q2 '21: -15.3M Q3 '21: -14.3M Q4 '21: -15.4M Q1 '22: -17.3M Q2 '22: -14M Q3 '22: -18M Q4 '22: -9.2M Q1 '23: -9.8M Q2 '23: -9.9M Q3 '23: -10.6M Q4 '23: -11.9M Q1 '24: -10.1M Q2 '24: -11.4M Q3 '24: -12.7M Q4 '24: -19.4M Q1 '25: -16.8M Q2 '25: -19.2M Q3 '25: -19.4M Q4 '25: -17.4M Q1 '26: -18.6M Q2 '26: -24.7M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 3M 6M 9M Q3 '21: 727K Q4 '21: 1.2M Q1 '22: 909K Q2 '22: 1.3M Q3 '22: 8.4M Q4 '22: 1.3M Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 0 Q3 '24: 0 Q4 '24: 0 Q1 '25: 0 Q2 '25: 0 Q3 '25: 279K Q4 '25: 260K Q1 '26: 370K Q2 '26: 273K Q1 '22 Q4 '22 Q3 '23 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-21M -14M -7M 0 7M 14M 21M Q3 '16: -2M Q4 '16: -2.3M Q1 '17: -2.5M Q2 '17: -1.2M Q3 '17: -3.4M Q4 '17: -4M Q1 '18: -5M Q2 '18: -5.7M Q3 '18: -6.8M Q4 '18: -6.3M Q1 '19: -7.3M Q2 '19: -9.7M Q3 '19: -8M Q4 '19: -9.2M Q1 '20: -9.6M Q2 '20: -7.9M Q3 '20: -8.5M Q4 '20: -9.3M Q1 '21: -11.7M Q2 '21: -16.4M Q3 '21: -13.3M Q4 '21: -12.7M Q1 '22: -15.6M Q2 '22: -12.8M Q3 '22: -10.6M Q4 '22: -8M Q1 '23: -6.6M Q2 '23: -9.2M Q3 '23: -10.5M Q4 '23: -6.8M Q1 '24: -9.8M Q2 '24: -8.4M Q3 '24: -9M Q4 '24: -9.1M Q1 '25: -13.5M Q2 '25: -12.8M Q3 '25: -13M Q4 '25: -14.8M Q1 '26: -14.6M Q2 '26: -18.7M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-21M -14M -7M 0 7M 14M 21M Q4 '15: -1.3M Q1 '16: -1.5M Q2 '16: -2.3M Q3 '16: -2M Q4 '16: -2.3M Q3 '17: -3.5M Q4 '17: -4.1M Q1 '18: -5.1M Q2 '18: -5.9M Q3 '18: -6.9M Q4 '18: -6.3M Q1 '19: -7.4M Q2 '19: -9.8M Q3 '19: -8.5M Q1 '20: -9.8M Q2 '20: -8M Q3 '20: -8.6M Q4 '20: -9.5M Q1 '21: -11.7M Q2 '21: -16.5M Q3 '21: -13.5M Q4 '21: -12.8M Q1 '22: -15.9M Q2 '22: -12.8M Q3 '22: -10.7M Q4 '22: -8M Q1 '23: -6.6M Q2 '23: -9.2M Q3 '23: -10.5M Q4 '23: -6.8M Q1 '24: -9.8M Q2 '24: -8.4M Q3 '24: -9.1M Q4 '24: -9.2M Q1 '25: -13.6M Q2 '25: -12.9M Q3 '25: -13.1M Q4 '25: -14.9M Q1 '26: -14.6M Q2 '26: -18.8M Q4 '16 Q3 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q2 '21: 26.5M Q3 '21: 29.6M Q1 '22: 29.7M Q2 '22: 31.5M Q3 '22: 37.2M Q1 '23: 37.4M Q2 '23: 46.1M Q3 '23: 56.9M Q1 '24: 57.1M Q2 '24: 57.2M Q3 '24: 61.1M Q1 '25: 67.1M Q2 '25: 67.3M Q3 '25: 67.4M Q1 '26: 68M Q2 '26: 69.2M Q3 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.40 -1.60 -0.80 0.00 0.80 1.60 2.40 Q3 '16: -0.79 Q4 '16: -0.87 Q1 '17: -0.88 Q2 '17: -1.08 Q3 '17: -1.39 Q4 '17: -1.71 Q1 '18: -1.99 Q2 '18: -2.10 Q3 '18: -2.22 Q4 '18: -2.20 Q1 '19: -2.18 Q2 '19: -2.19 Q3 '19: -2.12 Q4 '19: -2.27 Q1 '20: -2.35 Q2 '20: -2.33 Q3 '20: -2.27 Q4 '20: -2.15 Q1 '21: -2.29 Q2 '21: -2.34 Q3 '21: -2.31 Q4 '21: -2.29 Q1 '22: -2.16 Q2 '22: -2.02 Q3 '22: -2.03 Q4 '22: -1.73 Q1 '23: -1.41 Q2 '23: -1.19 Q3 '23: -0.89 Q4 '23: -0.88 Q1 '24: -0.80 Q2 '24: -0.78 Q3 '24: -0.80 Q4 '24: -0.91 Q1 '25: -0.98 Q2 '25: -1.06 Q3 '25: -1.14 Q4 '25: -1.08 Q1 '26: -1.10 Q2 '26: -1.18 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.